Roche struck a cancer drug licensing deal with China's Hansoh that could exceed $15 billion

发生了什么

Hansoh will receive $400 million upfront and keep rights to the programs in mainland China, Hong Kong, Macau and Taiwan

摘要按规则整理自下方来源原文

来源